Thomas Roberts, one of the founding members of the Multidisciplinary Association for Psychedelic Studies (MAPS), shares his extensive knowledge of psychedelics and his opinions on the future of psychedelic therapy. We discuss the directions that psychedelic research needs to take, and the reason why public benefit corporations will be the way forward for a burgeoning psychedelic industry.

For show links, go here: https://thethirdwave.co/podcast/episode-45-thomas-roberts/

Sign up to our ever-growing microdosing course here: https://thethirdwave.co/microdosing-course/